Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Sens. Ron Wyden and Chuck Grassley. Photo: Mark Wilson/Getty Images
The Senate is ready to start moving forward with a bipartisan bill to lower the cost of prescription drugs, after Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) released a detailed outline of the proposal this morning. The Finance Committee will debate the bill Thursday.
What's next: The Senate package would redesign Medicare's drug benefit and allow new payment models in Medicaid, among other changes. And it puts drug prices squarely at the center of Congress' fall agenda: House Speaker Nancy Pelosi's top health care aide said yesterday that House Democrats will introduce their own bill after the August recess.